Morpholino

MO2-gucy1a1

ID

ZDB-MRPHLNO-211201-1

Name

MO2-gucy1a1

Previous Names

Target

Sequence

5' - AAAAGAACATCTTACCAACTCGTGT - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

Splice-blocking MO.

Genome Resources

None

Target Location

Genomic Features

No data available

Expression

Gene expression in Wild Types + MO2-gucy1a1

Expressed Gene	Anatomy	Figures
gucy1a1	whole organism	FIGURE 3 from Vishnolia et al., 2021
gucy1b1	whole organism	FIGURE 3 from Vishnolia et al., 2021

Phenotype

Phenotype resulting from MO2-gucy1a1

Phenotype	Fish	Figures
blood circulation increased linear velocity, abnormal	AB + MO2-gucy1a1	FIGURE 3 from Vishnolia et al., 2021
blood circulation increased magnitude, abnormal	AB + MO2-gucy1a1	FIGURE 3 from Vishnolia et al., 2021
heart contraction increased frequency, abnormal	AB + MO2-gucy1a1	FIGURE 3 from Vishnolia et al., 2021
whole organism gucy1a1 expression decreased amount, abnormal	AB + MO2-gucy1a1	FIGURE 3 from Vishnolia et al., 2021

Phenotype of all Fish created by or utilizing MO2-gucy1a1

Phenotype	Fish	Conditions	Figures
heart contraction increased frequency, abnormal	AB + MO2-gucy1a1	standard conditions	FIGURE 3 from Vishnolia et al., 2021
whole organism gucy1a1 expression decreased amount, abnormal	AB + MO2-gucy1a1	standard conditions	FIGURE 3 from Vishnolia et al., 2021
blood circulation increased linear velocity, abnormal	AB + MO2-gucy1a1	standard conditions	FIGURE 3 from Vishnolia et al., 2021
blood circulation increased magnitude, abnormal	AB + MO2-gucy1a1	standard conditions	FIGURE 3 from Vishnolia et al., 2021
whole organism 3',5'-cyclic GMP decreased amount, abnormal	AB + MO2-gucy1a1	chemical treatment by environment: BAY 41-2272	FIGURE 4 from Vishnolia et al., 2021
blood vessel decreased diameter, abnormal	AB + MO1-gucy1b1 + MO2-gucy1a1	standard conditions	FIGURE 3 from Vishnolia et al., 2021
blood circulation increased linear velocity, exacerbated	AB + MO1-gucy1b1 + MO2-gucy1a1	standard conditions	FIGURE 3 from Vishnolia et al., 2021
blood circulation increased magnitude, exacerbated	AB + MO1-gucy1b1 + MO2-gucy1a1	standard conditions	FIGURE 3 from Vishnolia et al., 2021
whole organism 3',5'-cyclic GMP decreased amount, abnormal	AB + MO1-gucy1b1 + MO2-gucy1a1	chemical treatment by environment: BAY 41-2272	FIGURE 4 from Vishnolia et al., 2021
heart contraction increased frequency, abnormal	AB + MO1-gucy1b1 + MO2-gucy1a1	standard conditions	FIGURE 3 from Vishnolia et al., 2021

Citations